SHARE

Moderna’s Q1 trading driven by Covid vaccine sales

The US company has reported revenues of $6.07bn in the first quarter, compared with expectations of $4.62bn. The rise in turnover has been driven by Moderna’s Covid-19 vaccine, whose sales more than tripled to $5.9bn from the $1.7bn posted last year.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.